TP53 and cancer: Numerous cell lines with a variety of p53 mutations, originated from cancer patients, are in constant use in a great number of laboratories around the world; however, p53 mutational status and its effect on the cellular phenotype is still a controversial issue for many of the cell lines [17–19].